MedTrace Logo

REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue

NCT04525183 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2024-11-15

Study results available
· View outcomes & findings →

Summary

This study is testing whether a 6 week skills-based telehealth intervention can help ovarian cancer patients experiencing PARP inhibitor-related fatigue reduce the impact of fatigue on their daily life and activities.

Conditions

Interventions

BEHAVIORAL

Enhanced Usual Care (EOC)

Educational materials

BEHAVIORAL

REVITALIZE ACT Intervention

Six 60-75 minute telehealth sessions approximately once a week for 6-8 weeks

Sponsors & Collaborators

Principal Investigators

  • Alexi A Wright, MD, MPH · Dana-Farber Cancer Institute

  • Joanna J Arch, PhD · University of Colorado, Boulder

  • Hanneke MD Poort, PhD · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-02
Primary Completion
2022-08-09
Completion
2022-08-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04525183 on ClinicalTrials.gov